"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","characteristics_ch1.2","characteristics_ch1.3","molecule_ch1","extract_protocol_ch1","label_ch1","label_protocol_ch1","taxid_ch1","hyb_protocol","scan_protocol","description","data_processing","platform_id","contact_name","contact_email","contact_phone","contact_institute","contact_address","contact_city","contact_state","contact_zip/postal_code","contact_country","supplementary_file","data_row_count"
"GSM203261","R421P00048","GSM203261","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 55%","Percentage of Stroma: 25%","Percentage of BPH: 0%","Percentage of Atrophic Gland: 1%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203261/GSM203261.CEL.gz","22283"
"GSM203262","R422P00092","GSM203262","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 50%","Percentage of Stroma: 40%","Percentage of BPH: 0%","Percentage of Atrophic Gland: 15%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203262/GSM203262.CEL.gz","22283"
"GSM203263","R423P00094","GSM203263","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 40%","Percentage of BPH: 40%","Percentage of Atrophic Gland: 20%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203263/GSM203263.CEL.gz","22283"
"GSM203264","R424P00100","GSM203264","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 50%","Percentage of BPH: 50%","Percentage of Atrophic Gland: 0%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203264/GSM203264.CEL.gz","22283"
"GSM203265","R425P00102","GSM203265","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 60%","Percentage of Stroma: 30%","Percentage of BPH: 0%","Percentage of Atrophic Gland: 0%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203265/GSM203265.CEL.gz","22283"
"GSM203266","R426P00145","GSM203266","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 86%","Percentage of BPH: 0%","Percentage of Atrophic Gland: 3%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203266/GSM203266.CEL.gz","22283"
"GSM203267","R427P00146","GSM203267","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 50%","Percentage of Stroma: 40%","Percentage of BPH: 0%","Percentage of Atrophic Gland: 2%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203267/GSM203267.CEL.gz","22283"
"GSM203268","R428P00155","GSM203268","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 82%","Percentage of BPH: 10%","Percentage of Atrophic Gland: 7%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203268/GSM203268.CEL.gz","22283"
"GSM203269","R429P00163","GSM203269","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 100%","Percentage of BPH: 0%","Percentage of Atrophic Gland: 0%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203269/GSM203269.CEL.gz","22283"
"GSM203270","R430P00182","GSM203270","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 67%","Percentage of BPH: 27%","Percentage of Atrophic Gland: 2%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203270/GSM203270.CEL.gz","22283"
"GSM203271","R431P00183","GSM203271","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 90%","Percentage of BPH: 0%","Percentage of Atrophic Gland: 2%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203271/GSM203271.CEL.gz","22283"
"GSM203272","R432P00185","GSM203272","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 68%","Percentage of BPH: 31%","Percentage of Atrophic Gland: 0%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203272/GSM203272.CEL.gz","22283"
"GSM203273","R433P00224","GSM203273","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 80%","Percentage of Stroma: 4%","Percentage of BPH: 2%","Percentage of Atrophic Gland: 3%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203273/GSM203273.CEL.gz","22283"
"GSM203274","R434P00230","GSM203274","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 50%","Percentage of Stroma: 50%","Percentage of BPH: 0%","Percentage of Atrophic Gland: 0%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203274/GSM203274.CEL.gz","22283"
"GSM203275","R435P00262","GSM203275","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 35%","Percentage of Stroma: 45%","Percentage of BPH: 0%","Percentage of Atrophic Gland: 20%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203275/GSM203275.CEL.gz","22283"
"GSM203276","R436P00056","GSM203276","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 55%","Percentage of BPH: 37%","Percentage of Atrophic Gland: 5%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203276/GSM203276.CEL.gz","22283"
"GSM203277","R437P00057","GSM203277","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 55%","Percentage of BPH: 40%","Percentage of Atrophic Gland: 2%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203277/GSM203277.CEL.gz","22283"
"GSM203278","R438P00060","GSM203278","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 98%","Percentage of BPH: 0%","Percentage of Atrophic Gland: 12%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203278/GSM203278.CEL.gz","22283"
"GSM203279","R439P00089","GSM203279","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 94%","Percentage of BPH: 4%","Percentage of Atrophic Gland: 2%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203279/GSM203279.CEL.gz","22283"
"GSM203280","R440P00121","GSM203280","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 63%","Percentage of BPH: 26%","Percentage of Atrophic Gland: 8%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203280/GSM203280.CEL.gz","22283"
"GSM203281","R441P00225","GSM203281","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 70%","Percentage of Stroma: 20%","Percentage of BPH: 0%","Percentage of Atrophic Gland: 10%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203281/GSM203281.CEL.gz","22283"
"GSM203282","R442P00227","GSM203282","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 70%","Percentage of Stroma: 25%","Percentage of BPH: 0%","Percentage of Atrophic Gland: 0%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203282/GSM203282.CEL.gz","22283"
"GSM203283","R456P00301","GSM203283","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","normal prostate sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 80%","Percentage of BPH: 10%","Percentage of Atrophic Gland: 8%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203283/GSM203283.CEL.gz","22283"
"GSM203284","R457P00303","GSM203284","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 46%","Percentage of BPH: 46%","Percentage of Atrophic Gland: 3%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203284/GSM203284.CEL.gz","22283"
"GSM203285","R458P00307","GSM203285","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 96%","Percentage of BPH: 1%","Percentage of Atrophic Gland: 1%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203285/GSM203285.CEL.gz","22283"
"GSM203286","R459P00309","GSM203286","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 66%","Percentage of BPH: 29%","Percentage of Atrophic Gland: 3%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203286/GSM203286.CEL.gz","22283"
"GSM203287","R460P00321","GSM203287","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 21%","Percentage of Stroma: 59%","Percentage of BPH: 16%","Percentage of Atrophic Gland: 1%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203287/GSM203287.CEL.gz","22283"
"GSM203288","R461P00322","GSM203288","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 3%","Percentage of Stroma: 85%","Percentage of BPH: 3%","Percentage of Atrophic Gland: 8%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203288/GSM203288.CEL.gz","22283"
"GSM203289","R462P00324","GSM203289","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 8%","Percentage of Stroma: 74%","Percentage of BPH: 5%","Percentage of Atrophic Gland: 13%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203289/GSM203289.CEL.gz","22283"
"GSM203290","R463P00344","GSM203290","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 53%","Percentage of BPH: 35%","Percentage of Atrophic Gland: 10%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203290/GSM203290.CEL.gz","22283"
"GSM203291","R464P00422","GSM203291","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 57%","Percentage of Stroma: 35%","Percentage of BPH: 4%","Percentage of Atrophic Gland: 3%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203291/GSM203291.CEL.gz","22283"
"GSM203292","R465P00426","GSM203292","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 92%","Percentage of BPH: 4%","Percentage of Atrophic Gland: 2%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203292/GSM203292.CEL.gz","22283"
"GSM203293","R466P00431","GSM203293","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 14%","Percentage of Stroma: 71%","Percentage of BPH: 5%","Percentage of Atrophic Gland: 9%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203293/GSM203293.CEL.gz","22283"
"GSM203294","R467P00436","GSM203294","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 73%","Percentage of Stroma: 22%","Percentage of BPH: 0%","Percentage of Atrophic Gland: 1%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203294/GSM203294.CEL.gz","22283"
"GSM203295","R468P00438","GSM203295","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 70%","Percentage of Stroma: 29%","Percentage of BPH: 0%","Percentage of Atrophic Gland: 0%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203295/GSM203295.CEL.gz","22283"
"GSM203296","R469P00501","GSM203296","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 59%","Percentage of Stroma: 34%","Percentage of BPH: 2%","Percentage of Atrophic Gland: 4%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203296/GSM203296.CEL.gz","22283"
"GSM203297","R481P00302","GSM203297","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","normal prostate sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 63%","Percentage of BPH: 26%","Percentage of Atrophic Gland: 10%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203297/GSM203297.CEL.gz","22283"
"GSM203298","R482P00304","GSM203298","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 75%","Percentage of BPH: 19%","Percentage of Atrophic Gland: 5%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203298/GSM203298.CEL.gz","22283"
"GSM203299","R483P00305","GSM203299","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 20%","Percentage of Stroma: 72%","Percentage of BPH: 5%","Percentage of Atrophic Gland: 2%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203299/GSM203299.CEL.gz","22283"
"GSM203300","R484P00306","GSM203300","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 78%","Percentage of BPH: 14%","Percentage of Atrophic Gland: 9%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203300/GSM203300.CEL.gz","22283"
"GSM203301","R485P00308","GSM203301","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 34%","Percentage of Stroma: 57%","Percentage of BPH: 0%","Percentage of Atrophic Gland: 10%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203301/GSM203301.CEL.gz","22283"
"GSM203302","R487P00311","GSM203302","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 72%","Percentage of BPH: 24%","Percentage of Atrophic Gland: 3%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203302/GSM203302.CEL.gz","22283"
"GSM203303","R488P00312","GSM203303","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 9%","Percentage of Stroma: 78%","Percentage of BPH: 1%","Percentage of Atrophic Gland: 12%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203303/GSM203303.CEL.gz","22283"
"GSM203304","R489P00323","GSM203304","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 84%","Percentage of BPH: 12%","Percentage of Atrophic Gland: 4%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203304/GSM203304.CEL.gz","22283"
"GSM203305","R490P00325","GSM203305","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 43%","Percentage of Stroma: 50%","Percentage of BPH: 1%","Percentage of Atrophic Gland: 2%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203305/GSM203305.CEL.gz","22283"
"GSM203306","R491P00345","GSM203306","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 84%","Percentage of BPH: 13%","Percentage of Atrophic Gland: 4%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203306/GSM203306.CEL.gz","22283"
"GSM203307","R492P00424","GSM203307","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 46%","Percentage of Stroma: 45%","Percentage of BPH: 3%","Percentage of Atrophic Gland: 4%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203307/GSM203307.CEL.gz","22283"
"GSM203308","R493P00433","GSM203308","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 5%","Percentage of Stroma: 70%","Percentage of BPH: 7%","Percentage of Atrophic Gland: 15%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203308/GSM203308.CEL.gz","22283"
"GSM203309","R494P00442","GSM203309","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 70%","Percentage of Stroma: 26%","Percentage of BPH: 3%","Percentage of Atrophic Gland: 1%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203309/GSM203309.CEL.gz","22283"
"GSM203310","R495P00447","GSM203310","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 46%","Percentage of Stroma: 45%","Percentage of BPH: 2%","Percentage of Atrophic Gland: 4%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203310/GSM203310.CEL.gz","22283"
"GSM203311","R496P00521","GSM203311","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 48%","Percentage of Stroma: 36%","Percentage of BPH: 3%","Percentage of Atrophic Gland: 9%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203311/GSM203311.CEL.gz","22283"
"GSM203312","R521P00428","GSM203312","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 9%","Percentage of Stroma: 67%","Percentage of BPH: 14%","Percentage of Atrophic Gland: 10%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203312/GSM203312.CEL.gz","22283"
"GSM203313","R522P00584","GSM203313","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 33%","Percentage of Stroma: 60%","Percentage of BPH: 3%","Percentage of Atrophic Gland: 3%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203313/GSM203313.CEL.gz","22283"
"GSM203314","R523P00585","GSM203314","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 67%","Percentage of Stroma: 24%","Percentage of BPH: 9%","Percentage of Atrophic Gland: 1%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203314/GSM203314.CEL.gz","22283"
"GSM203315","R524P00603","GSM203315","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 68%","Percentage of BPH: 21%","Percentage of Atrophic Gland: 8%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203315/GSM203315.CEL.gz","22283"
"GSM203316","R525P00604","GSM203316","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 69%","Percentage of BPH: 22%","Percentage of Atrophic Gland: 6%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203316/GSM203316.CEL.gz","22283"
"GSM203317","R526P00605","GSM203317","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 26%","Percentage of Stroma: 57%","Percentage of BPH: 6%","Percentage of Atrophic Gland: 7%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203317/GSM203317.CEL.gz","22283"
"GSM203318","R527P00606","GSM203318","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 62%","Percentage of BPH: 37%","Percentage of Atrophic Gland: 1%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203318/GSM203318.CEL.gz","22283"
"GSM203319","R528P00607","GSM203319","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 50%","Percentage of BPH: 38%","Percentage of Atrophic Gland: 11%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203319/GSM203319.CEL.gz","22283"
"GSM203320","R529P00609","GSM203320","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 58%","Percentage of BPH: 37%","Percentage of Atrophic Gland: 3%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203320/GSM203320.CEL.gz","22283"
"GSM203321","R530P00643","GSM203321","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 34%","Percentage of Stroma: 56%","Percentage of BPH: 2%","Percentage of Atrophic Gland: 4%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203321/GSM203321.CEL.gz","22283"
"GSM203322","R531P00647","GSM203322","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 44%","Percentage of Stroma: 39%","Percentage of BPH: 8%","Percentage of Atrophic Gland: 7%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203322/GSM203322.CEL.gz","22283"
"GSM203323","R532P00648","GSM203323","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 68%","Percentage of BPH: 19%","Percentage of Atrophic Gland: 11%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203323/GSM203323.CEL.gz","22283"
"GSM203324","R533P00403","GSM203324","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 56%","Percentage of Stroma: 41%","Percentage of BPH: 1%","Percentage of Atrophic Gland: 1%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203324/GSM203324.CEL.gz","22283"
"GSM203325","R534P00429","GSM203325","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 80%","Percentage of BPH: 9%","Percentage of Atrophic Gland: 8%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203325/GSM203325.CEL.gz","22283"
"GSM203326","R535P00441","GSM203326","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 38%","Percentage of Stroma: 53%","Percentage of BPH: 1%","Percentage of Atrophic Gland: 5%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203326/GSM203326.CEL.gz","22283"
"GSM203327","R536P00445","GSM203327","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 59%","Percentage of BPH: 29%","Percentage of Atrophic Gland: 11%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203327/GSM203327.CEL.gz","22283"
"GSM203328","R537P00446","GSM203328","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 59%","Percentage of BPH: 29%","Percentage of Atrophic Gland: 11%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203328/GSM203328.CEL.gz","22283"
"GSM203329","R538P00541","GSM203329","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 88%","Percentage of BPH: 2%","Percentage of Atrophic Gland: 10%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203329/GSM203329.CEL.gz","22283"
"GSM203330","R539P00546","GSM203330","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 6%","Percentage of Stroma: 65%","Percentage of BPH: 20%","Percentage of Atrophic Gland: 8%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203330/GSM203330.CEL.gz","22283"
"GSM203331","R540P00550","GSM203331","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 70%","Percentage of BPH: 20%","Percentage of Atrophic Gland: 10%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203331/GSM203331.CEL.gz","22283"
"GSM203332","R541P00728","GSM203332","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 11%","Percentage of Stroma: 68%","Percentage of BPH: 12%","Percentage of Atrophic Gland: 10%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203332/GSM203332.CEL.gz","22283"
"GSM203333","R561P00761","GSM203333","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 80%","Percentage of Stroma: 20%","Percentage of BPH: 0%","Percentage of Atrophic Gland: 0%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203333/GSM203333.CEL.gz","22283"
"GSM203334","R562P00726","GSM203334","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 62%","Percentage of Stroma: 32%","Percentage of BPH: 1%","Percentage of Atrophic Gland: 2%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203334/GSM203334.CEL.gz","22283"
"GSM203335","R563P00723","GSM203335","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 71%","Percentage of BPH: 10%","Percentage of Atrophic Gland: 16%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203335/GSM203335.CEL.gz","22283"
"GSM203336","R564P00721","GSM203336","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 24%","Percentage of Stroma: 51%","Percentage of BPH: 11%","Percentage of Atrophic Gland: 10%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203336/GSM203336.CEL.gz","22283"
"GSM203337","R565P00156","GSM203337","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 28%","Percentage of Stroma: 58%","Percentage of BPH: 1%","Percentage of Atrophic Gland: 6%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203337/GSM203337.CEL.gz","22283"
"GSM203338","R566P00154","GSM203338","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 53%","Percentage of Stroma: 42%","Percentage of BPH: 0%","Percentage of Atrophic Gland: 3%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203338/GSM203338.CEL.gz","22283"
"GSM203339","R567P00147","GSM203339","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 38%","Percentage of Stroma: 61%","Percentage of BPH: 0%","Percentage of Atrophic Gland: 0%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203339/GSM203339.CEL.gz","22283"
"GSM203340","R568P00766","GSM203340","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 93%","Percentage of BPH: 0%","Percentage of Atrophic Gland: 0%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203340/GSM203340.CEL.gz","22283"
"GSM203341","R569P00764","GSM203341","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 75%","Percentage of Stroma: 23%","Percentage of BPH: 0%","Percentage of Atrophic Gland: 1%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203341/GSM203341.CEL.gz","22283"
"GSM203342","R570P00762","GSM203342","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 70%","Percentage of BPH: 22%","Percentage of Atrophic Gland: 2%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203342/GSM203342.CEL.gz","22283"
"GSM203343","R581P01061","GSM203343","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 24%","Percentage of Stroma: 58%","Percentage of BPH: 10%","Percentage of Atrophic Gland: 4%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203343/GSM203343.CEL.gz","22283"
"GSM203344","R582P01062","GSM203344","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 73%","Percentage of BPH: 1%","Percentage of Atrophic Gland: 12%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203344/GSM203344.CEL.gz","22283"
"GSM203345","R583P01063","GSM203345","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 62%","Percentage of BPH: 19%","Percentage of Atrophic Gland: 9%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203345/GSM203345.CEL.gz","22283"
"GSM203346","R584P01064","GSM203346","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 62%","Percentage of BPH: 30%","Percentage of Atrophic Gland: 5%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203346/GSM203346.CEL.gz","22283"
"GSM203347","R585P01065","GSM203347","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 70%","Percentage of Stroma: 29%","Percentage of BPH: 1%","Percentage of Atrophic Gland: 0%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203347/GSM203347.CEL.gz","22283"
"GSM203348","R586P01066","GSM203348","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 74%","Percentage of BPH: 20%","Percentage of Atrophic Gland: 4%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203348/GSM203348.CEL.gz","22283"
"GSM203349","R587P01067","GSM203349","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 82%","Percentage of BPH: 2%","Percentage of Atrophic Gland: 10%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203349/GSM203349.CEL.gz","22283"
"GSM203350","R588P01069","GSM203350","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 2%","Percentage of Stroma: 63%","Percentage of BPH: 13%","Percentage of Atrophic Gland: 12%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203350/GSM203350.CEL.gz","22283"
"GSM203351","R589P01070","GSM203351","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 82%","Percentage of BPH: 5%","Percentage of Atrophic Gland: 12%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203351/GSM203351.CEL.gz","22283"
"GSM203352","R590P01071","GSM203352","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 80%","Percentage of BPH: 9%","Percentage of Atrophic Gland: 3%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203352/GSM203352.CEL.gz","22283"
"GSM203353","R591P01072","GSM203353","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 84%","Percentage of BPH: 7%","Percentage of Atrophic Gland: 1%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203353/GSM203353.CEL.gz","22283"
"GSM203354","R592P01081","GSM203354","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","normal prostate sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 72%","Percentage of BPH: 3%","Percentage of Atrophic Gland: 17%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203354/GSM203354.CEL.gz","22283"
"GSM203355","R601P01083","GSM203355","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","normal prostate sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 92%","Percentage of BPH: 1%","Percentage of Atrophic Gland: 4%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203355/GSM203355.CEL.gz","22283"
"GSM203356","R621P01206","GSM203356","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 81%","Percentage of BPH: 0%","Percentage of Atrophic Gland: 9%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203356/GSM203356.CEL.gz","22283"
"GSM203357","R622P01005","GSM203357","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 9%","Percentage of Stroma: 78%","Percentage of BPH: 5%","Percentage of Atrophic Gland: 6%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203357/GSM203357.CEL.gz","22283"
"GSM203358","R623P01188","GSM203358","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 92%","Percentage of BPH: 2%","Percentage of Atrophic Gland: 4%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203358/GSM203358.CEL.gz","22283"
"GSM203359","R624P00744","GSM203359","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 100%","Percentage of BPH: 0%","Percentage of Atrophic Gland: 0%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203359/GSM203359.CEL.gz","22283"
"GSM203360","R625P00906","GSM203360","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 53%","Percentage of BPH: 32%","Percentage of Atrophic Gland: 13%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203360/GSM203360.CEL.gz","22283"
"GSM203361","R626P01184","GSM203361","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 64%","Percentage of BPH: 26%","Percentage of Atrophic Gland: 10%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203361/GSM203361.CEL.gz","22283"
"GSM203362","R641P00801","GSM203362","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 70%","Percentage of BPH: 19%","Percentage of Atrophic Gland: 6%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203362/GSM203362.CEL.gz","22283"
"GSM203363","R642P00802","GSM203363","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 70%","Percentage of BPH: 21%","Percentage of Atrophic Gland: 6%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203363/GSM203363.CEL.gz","22283"
"GSM203364","R643P00803","GSM203364","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 76%","Percentage of BPH: 14%","Percentage of Atrophic Gland: 7%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203364/GSM203364.CEL.gz","22283"
"GSM203365","R644P00804","GSM203365","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 76%","Percentage of BPH: 10%","Percentage of Atrophic Gland: 13%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203365/GSM203365.CEL.gz","22283"
"GSM203366","R645P00805","GSM203366","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 76%","Percentage of BPH: 17%","Percentage of Atrophic Gland: 5%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203366/GSM203366.CEL.gz","22283"
"GSM203367","R646P00806","GSM203367","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 88%","Percentage of BPH: 5%","Percentage of Atrophic Gland: 4%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203367/GSM203367.CEL.gz","22283"
"GSM203368","R647P01068","GSM203368","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 64%","Percentage of BPH: 31%","Percentage of Atrophic Gland: 3%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203368/GSM203368.CEL.gz","22283"
"GSM203369","R648P01085","GSM203369","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 35%","Percentage of Stroma: 52%","Percentage of BPH: 2%","Percentage of Atrophic Gland: 12%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203369/GSM203369.CEL.gz","22283"
"GSM203370","R649P01087","GSM203370","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 67%","Percentage of BPH: 15%","Percentage of Atrophic Gland: 18%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203370/GSM203370.CEL.gz","22283"
"GSM203371","R650P01104","GSM203371","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 99%","Percentage of BPH: 0%","Percentage of Atrophic Gland: 0%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203371/GSM203371.CEL.gz","22283"
"GSM203372","R651P01105","GSM203372","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 70%","Percentage of BPH: 17%","Percentage of Atrophic Gland: 13%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203372/GSM203372.CEL.gz","22283"
"GSM203373","R652P01186","GSM203373","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 87%","Percentage of BPH: 9%","Percentage of Atrophic Gland: 3%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203373/GSM203373.CEL.gz","22283"
"GSM203374","R653P01205","GSM203374","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 61%","Percentage of Stroma: 36%","Percentage of BPH: 2%","Percentage of Atrophic Gland: 3%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203374/GSM203374.CEL.gz","22283"
"GSM203375","R661P00807","GSM203375","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 88%","Percentage of BPH: 0%","Percentage of Atrophic Gland: 9%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203375/GSM203375.CEL.gz","22283"
"GSM203376","R662P00808","GSM203376","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 67%","Percentage of Stroma: 31%","Percentage of BPH: 0%","Percentage of Atrophic Gland: 1%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203376/GSM203376.CEL.gz","22283"
"GSM203377","R663P00904","GSM203377","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 97%","Percentage of BPH: 0%","Percentage of Atrophic Gland: 2%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203377/GSM203377.CEL.gz","22283"
"GSM203378","R664P01207","GSM203378","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 75%","Percentage of BPH: 14%","Percentage of Atrophic Gland: 7%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203378/GSM203378.CEL.gz","22283"
"GSM203379","R668P01211","GSM203379","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 13%","Percentage of Stroma: 69%","Percentage of BPH: 11%","Percentage of Atrophic Gland: 4%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203379/GSM203379.CEL.gz","22283"
"GSM203380","R681P00686","GSM203380","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 14%","Percentage of Stroma: 54%","Percentage of BPH: 24%","Percentage of Atrophic Gland: 10%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203380/GSM203380.CEL.gz","22283"
"GSM203381","R682P00687","GSM203381","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 47%","Percentage of BPH: 46%","Percentage of Atrophic Gland: 7%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203381/GSM203381.CEL.gz","22283"
"GSM203382","R683P01102","GSM203382","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 41%","Percentage of Stroma: 40%","Percentage of BPH: 8%","Percentage of Atrophic Gland: 8%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203382/GSM203382.CEL.gz","22283"
"GSM203383","R684P01106","GSM203383","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 58%","Percentage of Stroma: 29%","Percentage of BPH: 1%","Percentage of Atrophic Gland: 13%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203383/GSM203383.CEL.gz","22283"
"GSM203384","R685P01201","GSM203384","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 32%","Percentage of Stroma: 54%","Percentage of BPH: 9%","Percentage of Atrophic Gland: 5%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203384/GSM203384.CEL.gz","22283"
"GSM203385","R686P01236","GSM203385","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 34%","Percentage of Stroma: 47%","Percentage of BPH: 10%","Percentage of Atrophic Gland: 6%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203385/GSM203385.CEL.gz","22283"
"GSM203386","R701P01101","GSM203386","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 61%","Percentage of BPH: 27%","Percentage of Atrophic Gland: 11%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203386/GSM203386.CEL.gz","22283"
"GSM203387","R702P01103","GSM203387","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 0%","Percentage of Stroma: 85%","Percentage of BPH: 7%","Percentage of Atrophic Gland: 1%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203387/GSM203387.CEL.gz","22283"
"GSM203388","R703P01230","GSM203388","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 36%","Percentage of Stroma: 54%","Percentage of BPH: 1%","Percentage of Atrophic Gland: 6%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203388/GSM203388.CEL.gz","22283"
"GSM203389","R704P01242","GSM203389","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor:not Known","Percentage of Stroma:not Known","Percentage of BPH:not Known","Percentage of Atrophic Gland:not Known","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203389/GSM203389.CEL.gz","22283"
"GSM203390","R705P01282","GSM203390","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 47%","Percentage of Stroma: 44%","Percentage of BPH: 0%","Percentage of Atrophic Gland: 6%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203390/GSM203390.CEL.gz","22283"
"GSM203391","R706P01301","GSM203391","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor:not Known","Percentage of Stroma:not Known","Percentage of BPH:not Known","Percentage of Atrophic Gland:not Known","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203391/GSM203391.CEL.gz","22283"
"GSM203392","R707P01302","GSM203392","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor:not Known","Percentage of Stroma:not Known","Percentage of BPH:not Known","Percentage of Atrophic Gland:not Known","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203392/GSM203392.CEL.gz","22283"
"GSM203393","R708P01308","GSM203393","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor:not Known","Percentage of Stroma:not Known","Percentage of BPH:not Known","Percentage of Atrophic Gland:not Known","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203393/GSM203393.CEL.gz","22283"
"GSM203394","R721P00481","GSM203394","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 38%","Percentage of Stroma: 49%","Percentage of BPH: 3%","Percentage of Atrophic Gland: 11%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203394/GSM203394.CEL.gz","22283"
"GSM203395","R722P00829","GSM203395","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 28%","Percentage of Stroma: 69%","Percentage of BPH: 1%","Percentage of Atrophic Gland: 3%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203395/GSM203395.CEL.gz","22283"
"GSM203396","R723P00881","GSM203396","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 69%","Percentage of Stroma: 22%","Percentage of BPH: 1%","Percentage of Atrophic Gland: 4%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203396/GSM203396.CEL.gz","22283"
"GSM203397","R724P00901","GSM203397","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 48%","Percentage of Stroma: 30%","Percentage of BPH: 17%","Percentage of Atrophic Gland: 3%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203397/GSM203397.CEL.gz","22283"
"GSM203398","R725P00941","GSM203398","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 78%","Percentage of Stroma: 13%","Percentage of BPH: 2%","Percentage of Atrophic Gland: 5%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203398/GSM203398.CEL.gz","22283"
"GSM203399","R726P01003","GSM203399","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 33%","Percentage of Stroma: 66%","Percentage of BPH: 1%","Percentage of Atrophic Gland: 1%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203399/GSM203399.CEL.gz","22283"
"GSM203400","R727P01204","GSM203400","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor: 62%","Percentage of Stroma: 31%","Percentage of BPH: 3%","Percentage of Atrophic Gland: 3%","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203400/GSM203400.CEL.gz","22283"
"GSM203401","R741P00668","GSM203401","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor:not Known","Percentage of Stroma:not Known","Percentage of BPH:not Known","Percentage of Atrophic Gland:not Known","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203401/GSM203401.CEL.gz","22283"
"GSM203402","R742P00670","GSM203402","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor:not Known","Percentage of Stroma:not Known","Percentage of BPH:not Known","Percentage of Atrophic Gland:not Known","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203402/GSM203402.CEL.gz","22283"
"GSM203403","R743P00701","GSM203403","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor:not Known","Percentage of Stroma:not Known","Percentage of BPH:not Known","Percentage of Atrophic Gland:not Known","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203403/GSM203403.CEL.gz","22283"
"GSM203404","R744P00748","GSM203404","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor:not Known","Percentage of Stroma:not Known","Percentage of BPH:not Known","Percentage of Atrophic Gland:not Known","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203404/GSM203404.CEL.gz","22283"
"GSM203405","R745P00782","GSM203405","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor:not Known","Percentage of Stroma:not Known","Percentage of BPH:not Known","Percentage of Atrophic Gland:not Known","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203405/GSM203405.CEL.gz","22283"
"GSM203406","R746P00821","GSM203406","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor:not Known","Percentage of Stroma:not Known","Percentage of BPH:not Known","Percentage of Atrophic Gland:not Known","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203406/GSM203406.CEL.gz","22283"
"GSM203407","R748P01234","GSM203407","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor:not Known","Percentage of Stroma:not Known","Percentage of BPH:not Known","Percentage of Atrophic Gland:not Known","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203407/GSM203407.CEL.gz","22283"
"GSM203408","R749P01262","GSM203408","Public on Jun 22 2007","Jun 21 2007","Aug 14 2011","RNA","1","prostate cancer sample","Homo sapiens","Percentage of Tumor:not Known","Percentage of Stroma:not Known","Percentage of BPH:not Known","Percentage of Atrophic Gland:not Known","total RNA","QiaGen Rneasy extraction of total RNA was performed according to the manufacturer's instructions.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","GeneChips were scanned using the Affymetrix Scanner.","prostate","The data were analyzed and normalized with RMA.","GPL96","Yipeng,,Wang","ywang@sdibr.org","8585813960","Vaccine Research Institute of San Diego"," ","San Diego","CA","92121","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM203nnn/GSM203408/GSM203408.CEL.gz","22283"
